Personal profile
Research interests
Personal Biographical Information
I received B.Sc. degree in Medicinal Chemistry from Bar-Ilan University (1996) and direct Ph.D. (Summa cum laude) degree in Pharmacology/Medicinal Chemistry (2003) from Pharmacy School, Faculty of Medicine, Hebrew University of Jerusalem. In between 2003-2007, I was a post-doctoral research fellow at the Department of Physiology, Medical School, at UCSF and in California Pacific Medical Center Research Institute at San Francisco (biochemistry of ALS and prostate cancer). From 2009 I am a faculty member in Department of Chemistry at Bar-Ilan University. My research topic is medicinal chemistry in general and in particular: development of the drug candidates against diabetes, ALS, autoimmune diseases and prostate cancer.
Research Lab
Our group uses a multidisciplinary approach to develop new drug candidates. We apply pharmacology, molecular biology, biochemistry, computer molecular modeling and nanotechnology methods in our research. We believe that an optimal drug-development project begins with a deep understanding of molecular pharmacology and choice of a key target protein which plays an important role in the pathogenesis of a specific disease. Then, based on computer molecular modeling and the 3D structure of the target protein, possible small organic molecules that might interact with the protein are identified in silico. Dozens of new molecules are then synthesized and tested in vitro in tissue culture, and finally the therapeutic effect of the lead compounds are investigated in animal models. All these steps we conduct in our lab.
Our research group aims to develop new drug candidates against several devastating human diseases. We believe that medicinal chemists have a chance to improve the health and well-being of human society.
Education/Academic qualification
PhD, Hebrew University of Jerusalem
Jan 1997 → Jun 2004
Award Date: 15 Jun 2004
Bachelor, Bar-Ilan University
Oct 1992 → Jul 1995
Award Date: 1 Jul 1995
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A novel 2-oxopyrrolidine derivative (LN-53) efficiently induces Nrf-2 signaling pathway activation in human epidermal keratinocytes
Sarac, B. E., Nissim, L., Karaguzel, D., Arik, G., Kahremany, S., Korshin, E. E., Gruzman, A. & Karaaslan, C., 2025, (Accepted/In press) In: Pharmacological Reports.Research output: Contribution to journal › Article › peer-review
-
Evaluation of the Recent Dynamics for Funding Medicinal Chemistry Projects in Academia. Results of a Survey Conducted by IUPAC Division VII (Chemistry and Human Health)
Rothstein, A., Chorghade, M., Ibrahim, H., Ganesan, A., Erhardt, P. W., Schnorrenberg, G. & Gruzman, A., 13 Feb 2025, In: Journal of Medicinal Chemistry. 68, 3, p. 2095-2104 10 p.Research output: Contribution to journal › Review article › peer-review
-
A Unified Synthesis of Electron-Deficient 1,4- and 1,1,4-Substituted 1,3-Dienes through a Base-Promoted Allylation Followed by Retro-Michael Vinylogous Dehydrosulfinylation
Rothstein, A., Trifonov, L., Keidar, N., Afri, M., Korshin, E. E. & Gruzman, A., 11 Oct 2024, In: Organic Letters. 26, 40, p. 8565-8571 7 p.Research output: Contribution to journal › Article › peer-review
-
Intracellular spatially-targeted chemical chaperones increase native state stability of mutant SOD1 barrel
Ribeiro, S. S., Gnutt, D., Azoulay-Ginsburg, S., Fetahaj, Z., Spurlock, E., Lindner, F., Kuz, D., Cohen-Erez, Y., Rapaport, H., Israelson, A., Gruzman, A. L. & Ebbinghaus, S., 1 Sep 2023, In: Biological Chemistry. 404, 10, p. 909-930 22 p.Ben-Gurion University of the Negev, Bar-Ilan University
Research output: Contribution to journal › Article › peer-review
Open Access -
Moderately lipophilic 2-(Het)aryl-6-dithioacetals, 2-phenyl-1,4-benzodioxane-6-dithioacetals and 2-phenylbenzofuran-5-dithioacetals: Synthesis and primary evaluation as potential antidiabetic AMPK-activators
Lepechkin-Zilbermintz, V., Bareket, D., Gonnord, V., Steffen, A., Morice, C., Michaut, M., Munder, A., Korshin, E. E., Contreras, J. M., Cerasi, E., Sasson, S. & Gruzman, A., 3 May 2023, In: Bioorganic and Medicinal Chemistry. 87, 117303.Bar-Ilan University, The Hebrew University of Jerusalem
Research output: Contribution to journal › Article › peer-review